GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Laboratories Ltd (BOM:538964) » Definitions » EV-to-FCF

Mercury Laboratories (BOM:538964) EV-to-FCF : (As of May. 30, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mercury Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Mercury Laboratories's Enterprise Value is ₹1,064.1 Mil. Mercury Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.0 Mil. Therefore, Mercury Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Mercury Laboratories's EV-to-FCF or its related term are showing as below:

BOM:538964' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 106.15
Current: 74.1

During the past 10 years, the highest EV-to-FCF of Mercury Laboratories was 106.15. The lowest was 0.00. And the median was 0.00.

BOM:538964's EV-to-FCF is ranked worse than
83.58% of 530 companies
in the Drug Manufacturers industry
Industry Median: 22.78 vs BOM:538964: 74.10

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-30), Mercury Laboratories's stock price is ₹890.00. Mercury Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹34.240. Therefore, Mercury Laboratories's PE Ratio for today is 25.99.


Mercury Laboratories EV-to-FCF Historical Data

The historical data trend for Mercury Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Laboratories EV-to-FCF Chart

Mercury Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 211.02 8.89 22.26 17.70 48.87

Mercury Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 48.87 - - -

Competitive Comparison of Mercury Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's EV-to-FCF falls into.



Mercury Laboratories EV-to-FCF Calculation

Mercury Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1064.147/0
=

Mercury Laboratories's current Enterprise Value is ₹1,064.1 Mil.
Mercury Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mercury Laboratories  (BOM:538964) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Mercury Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=890.00/34.240
=25.99

Mercury Laboratories's share price for today is ₹890.00.
Mercury Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34.240.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Mercury Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Mercury Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Mercury Laboratories (BOM:538964) Business Description

Traded in Other Exchanges
N/A
Address
Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and internationally, of which key revenue is derived from sales made in India.

Mercury Laboratories (BOM:538964) Headlines

No Headlines